175 related articles for article (PubMed ID: 5730657)
1. [Eye pigmentation disorders in patients treated with phenothiazines].
Sizaret P; Quéré M; Degiovanni E; Degiovanni A
Encephale; 1968; 57(6):515-24. PubMed ID: 5730657
[No Abstract] [Full Text] [Related]
2. [Ultrastructural study of ocular pigmentation due to phenothiazines].
Sizaret P; Rossazza C; Brassart B
Rev Otoneuroophtalmol; 1975; 47(4):247-51. PubMed ID: 1215727
[No Abstract] [Full Text] [Related]
3. Prolonged pharmacotherapy and the eye. A symposium. The antimalarials and the tranquilizers.
Rubin M
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:67-76. PubMed ID: 4233735
[No Abstract] [Full Text] [Related]
4. Ocular complications related to phenothiazines.
Siddall JR
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:10-3. PubMed ID: 4876740
[No Abstract] [Full Text] [Related]
5. Ocular complications of phenothiazines.
Mathalone MB
Trans Ophthalmol Soc U K (1962); 1966; 86():77-88. PubMed ID: 5226613
[No Abstract] [Full Text] [Related]
6. Phenothiazines in ophthalmology.
Siddall JR
Int Ophthalmol Clin; 1967; 7(1):207-15. PubMed ID: 5599926
[No Abstract] [Full Text] [Related]
7. [Endocrinologic principles of pigmentation disorders due to contraceptives].
Leonhardi G
Arch Dermatol Forsch; 1972; 244():495-9. PubMed ID: 4648759
[No Abstract] [Full Text] [Related]
8. [Complications on the part of the eyes during employment of psychotropic drugs (review of the foreign literature)].
Gol'dovskaia IL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(6):935-9. PubMed ID: 4905472
[No Abstract] [Full Text] [Related]
9. Ocular effects of phenothiazine derivatives and reversibility.
Mathalone MB
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:29-35. PubMed ID: 5672561
[No Abstract] [Full Text] [Related]
10. Phenothiazine retinopathy.
Boet DJ
Ophthalmologica; 1969; 158 Suppl():574-82. PubMed ID: 5359756
[No Abstract] [Full Text] [Related]
11. [Ocular pigmentation and phenothiazine derivatives].
Calluaud JL; Di Battista JC; Douenne JL; Lagoutte F
Bull Soc Ophtalmol Fr; 1977; 77(7-8):661-4. PubMed ID: 26474
[No Abstract] [Full Text] [Related]
12. Ocular complications of chlorpromazine therapy.
Petrohelos MA; Tricoulis D
Ophthalmologica; 1969; 158 Suppl():469-76. PubMed ID: 4982681
[No Abstract] [Full Text] [Related]
13. [Pigment and internal diseases].
Krebs A
Bull Schweiz Akad Med Wiss; 1968 Jan; 23(5):483-502. PubMed ID: 4300028
[No Abstract] [Full Text] [Related]
14. Ocular pigmentation, extrapyramidal symptoms and phenothiazine dosage.
Wheeler RH; Bhalerao VR; Gilkes MJ
Br J Psychiatry; 1969 Jun; 115(523):687-90. PubMed ID: 5806859
[No Abstract] [Full Text] [Related]
15. Toxic effects of phenothiazines on the eye.
Boet DJ
Doc Ophthalmol; 1970 Jul; 28(1):1-69. PubMed ID: 5312274
[No Abstract] [Full Text] [Related]
16. Melanin pigmentation.
Szabo G
Dis Nerv Syst; 1968 Mar; 29(3):Suppl:58-62. PubMed ID: 4386202
[No Abstract] [Full Text] [Related]
17. [Ophthalmologic study of patients receiving psychotropic drugs].
Gol'dovskaia IL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1970 May; 70(5):759-62. PubMed ID: 5311196
[No Abstract] [Full Text] [Related]
18. [Eye and skin complications with long-term treatment of psychopharmaceutic agents].
Gunby B
Nord Psykiatr Tidsskr; 1967; 21(5):378-88. PubMed ID: 5587721
[No Abstract] [Full Text] [Related]
19. [The neuroleptic syndrome. Attempted systematization of primary and secondary effects observed during neuroleptic treatments].
Lambert PA
Encephale; 1971; 60(4):335-49. PubMed ID: 5004893
[No Abstract] [Full Text] [Related]
20. [The analytical electron microscopic study of the corneal and conjunctival deposits of pigments and other substances. Part 2: Conjunctival argyrosis (author's transl)].
Kanai A; Yamaguchi T; Nakajima A
Nippon Ganka Gakkai Zasshi; 1976 Jul; 80(7):385-9. PubMed ID: 986757
[No Abstract] [Full Text] [Related]
[Next] [New Search]
